Drugs / Nigella sativa seed
last change Apr 2022 re-read 2 minutes ago

Nigella sativa seed

Traditional medicine (herbal / TCM)

Developed for
hyperlipidemia · COVID-19
Investigated by
Aga Khan University · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Trials 2 · a red edge is where a trial was stopped

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/21 trial
Phase 1/2 NCT00327054 Feb 2006 → Mar 2007 diabetes mellitus, hyperlipidemia, hypertensive disorder, metabolic syndrome X Aga Khan University Completed No outcome recorded
Phase not applicable1 trial
NCT04686461 Oct 2019 → Jan 2021 Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Unknown No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT04767087 Comparator Mar 2021 → Feb 2022 COVID-19 Sohaib Ashraf Unknown No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as Nigella sativa seed ClinicalTrials.gov intervention name — accepted as the source's own label NCT00327054
1

NCT04767087

Known as Kalonji “Half of the respondents received powdered N. sativa (Kalonji) seed in capsule and the rest received a placebo.” PMID 19500003 Jun 2009
Known as N. sativa “Half of the respondents received powdered N. sativa (Kalonji) seed in capsule and the rest received a placebo.” PMID 19500003 Jun 2009
Known as Nigella sativa seed extract Nigella sativa seed extract, bee wax, white petrolatum, stearyl alcohol” NCT04686461
Modality Traditional medicine (herbal / TCM) “The seed extracts from Nigella sativa is used by Unani physicians of traditional medicine (Hakims or Tabibs) and Ayurvedic practitioners (Vaids) in the treatment of several...” PMID 19500003 Jun 2009
Route Topical “Then a topical ointment will be prepared from Nigella sativa extract and supplied to the arsenical keratosis patient at two weeks interval.” NCT04686461